Skip to main content
Equibles

Catherine Mazzacco

Board Member

Sight Sciences, Inc. (SGHT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Sight Sciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get SGHT alerts

About Catherine Mazzacco

Catherine Mazzacco is recorded as Board Member at Sight Sciences, Inc. (SGHT) since January 1, 2023. The newest filing on record that lists Catherine Mazzacco as Board Member at Sight Sciences, Inc. (SGHT) is dated April 22, 2026. Catherine Mazzacco was last confirmed as Board Member at Krystal Biotech, Inc. (KRYS) in a filing dated April 4, 2024. Krystal Biotech, Inc. reported in an 8-K filed March 6, 2023 that Catherine Mazzacco was appointed independent member of the Board, effective March 6, 2023. Sight Sciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Sight Sciences, Inc. includes Paul Badawi (CEO and Board Member), James Rodberg (CFO), Jim Rodberg (CFO) and 7 others.

“On March 6, 2023, the Board of Directors (the "Board") of Krystal Biotech, Inc. (the "Company") approved an increase in the size of the Board from eight (8) directors to nine (9) directors and appointed Catherine Mazzacco as an independent member of the Board to fill the vacancy created by the increase in the size of the Board.”
Krystal Biotech, Inc. Form 8-K, filed March 6, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Sight Sciences, Inc.

Recent activity